Author

Sara Ataei

Observed names: S Ataei, S. Ataei, Sarah Ataei
ORCID: 0000-0002-1211-8132
Observed ORCID: 0000-0002-1211-8132
OpenAlex ID: A5061624203
2013 · Molouk Hadjibabaie, Shirinsadat Badri, et al. · Cancer Chemotherapy and Pharmacology · 59
2018 · MasoumehTaravati Javad, Maryam Mehrpooya, et al. · Journal of Education and Health Promotion · 47
2015 · Ali Mohammadian, Shirin Moradkhani, et al. · Journal of Herbmed Pharmacology · 40
2021 · Atefeh Gholami, Sara Ataei, et al. · Oxidative Medicine and Cellular Longevity · 38
2018 · Ghazal Hashemi, Mahtabalsadat Mirjalili, et al. · Current Rheumatology Reviews · 37
2021 · Shirinsadat Badri, Sahar Vahdat, et al. · Journal of Research in Pharmacy Practice · 23
2017 · Maryam Mehrpooya, Azadeh Eshraghi, et al. · Reviews on Recent Clinical Trials · 23
2019 · Sara Ataei, Leila Kord, et al. · Reviews on Recent Clinical Trials · 22
2021 · Masoud Ghiasian, Zahra Niroomandi, et al. · Complementary Therapies in Clinical Practice · 20
2022 · Mehrnoush Mehrarya, M. R. Mozafari, et al. · Current Drug Delivery · 13
2021 · Shirinsadat Badri, Sahar Vahdat, et al. · Journal of Research in Pharmacy Practice · 13
2021 · Saeed Abdi, Mohammad Abbasinazari, et al. · PubMed Central · 11
2024 · Fahime Nasr Esfahani, Sahand Karimi, et al. · Advanced Pharmaceutical Bulletin · 10
2017 · Maryam Mehrpouya, Sara Ataei, et al. · Journal of Applied Pharmaceutical Science · 10
2020 · Foroud Shahbazi, Fakhrossadat Farvadi, et al. · Oriental Pharmacy and Experimental Medicine · 9
2022 · Zahra Azadbakht, Firozeh Sajedi, et al. · Journal of Basic and Clinical Physiology and Pharmacology · 8
2022 · Mohammad Ali Sahraian, Amir Mohammad Salehi, et al. · Multiple Sclerosis and Related Disorders · 7
2022 · Saeed Abdi, Sara Ataei, et al. · Iranian journal of pharmaceutical research · 7
Works count: 59
Citation count: 598
H-index: 14
I10-index: 19
Year
Topic
Type